Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer

Go back to Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer
(NASDAQ: TENX) Delayed: 1.85 -0.06 (3.14%)
Previous Close $1.91    52 Week High $3.40 
Open $1.91    52 Week Low $1.34 
Day High $1.91    P/E N/A 
Day Low $1.84    EPS $0.00 
Volume 375,287